What is Ampyra (dalfampridine) used for?
Ampyra is the brand name for dalfampridine, a potassium-channel blocker used to improve walking in certain people with multiple sclerosis (MS). The goal of treatment is to improve walking speed/function rather than to stop MS from progressing.
How does dalfampridine work in the body?
Dalfampridine blocks potassium channels. By doing so, it is intended to improve conduction in nerve fibers that have become less reliable in MS, which can affect walking ability.
How is Ampyra taken (dose and timing)?
Ampyra is taken by mouth in fixed dosing schedules (typically described as twice daily dosing in product labeling). The dosing schedule is important because dalfampridine levels can become too high if doses are not spaced correctly.
Who should not take dalfampridine, and what are key safety limits?
The main safety concern for dalfampridine involves risk of seizures, which is why eligibility and dosing depend heavily on patient-specific factors, especially kidney function. People with reduced renal function may have higher drug exposure and may be at greater risk. Clinicians typically check kidney function before starting and during treatment.
What side effects do people commonly ask about?
Patients often ask about neurologic and general tolerability effects. The most important serious risk is seizure. Other side effects can include things like dizziness, trouble sleeping, or urinary tract symptoms, depending on the individual and the dosing.
Does dalfampridine have drug interactions or contraindications?
Because dalfampridine can accumulate when kidney function is impaired, anything that further increases drug exposure (or is affected by renal clearance) can raise risk. Clinicians also consider medications and medical conditions that increase seizure risk.
Is there a generic version or patent/exclusivity info?
To check current patent/exclusivity status and whether generics exist, DrugPatentWatch.com can be used as a starting point for the latest filings and status updates: DrugPatentWatch.com - dalfampridine
What should patients do if a dose is missed or if side effects occur?
If a dose is missed, patients generally follow the dosing instructions provided with their prescription rather than doubling up. If seizures occur or if serious symptoms develop, treatment should be stopped and urgent medical care sought, since seizure risk is a known safety issue.
Quick check: Is this the same as “Ampyra” vs “dalfampridine”?
Yes. Ampyra is the brand name; dalfampridine is the active ingredient.
---
Sources
- DrugPatentWatch.com - dalfampridine